Autolus Therapeutics plc (NASDAQ: AUTL)
| Pre-Market |
Intra-Day |
After-Hours |
| 1.60 (-0.01 / -0.62%) |
1.60 (-0.01 / -0.62%) |
1.64 (0.04 / 2.50%) |
| 17-Apr 09:08 |
17-Apr 16:00 |
17-Apr 18:25 |
Sector:
Healthcare || Industry:
Biotechnology
| Previous Close |
1.61 |
Year Low |
1.15 |
| Open |
1.61 |
Year High |
2.70 |
| Day Low |
1.60 |
Price Avg 50 |
1.49 |
| Day High |
1.69 |
Price Avg 200 |
1.66 |
| Volume |
2.13 M |
Market Cap |
425.83 M |
News
Analysis
| AUTL |
-0.62 |
6.67 |
5.96 |
15.94 |
-1.23 |
11.89 |
Earnings
| 03/27/2026 |
BMO |
AUTL |
Autolus Therapeutics |
Q4 2025 |
EPS |
-0.27 |
-0.34 |
-25.93 |
-0.09 |
-277.80 |
|
| 03/27/2026 |
BMO |
AUTL |
Autolus Therapeutics |
Q4 2025 |
REV |
24.48 M |
24.29 M |
-0.78 |
|
0.00 |
|
| 11/12/2025 |
BMO |
AUTL |
Autolus Therapeutics |
Q3 2025 |
EPS |
-0.23 |
-0.30 |
-30.43 |
-0.31 |
3.20 |
|
| 11/12/2025 |
BMO |
AUTL |
Autolus Therapeutics |
Q3 2025 |
REV |
21.31 M |
21.19 M |
-0.55 |
|
|
|
| 08/12/2025 |
BMO |
AUTL |
Autolus Therapeutics |
Q2 2025 |
EPS |
-0.23 |
-0.18 |
21.74 |
-0.22 |
18.20 |
|
| 08/12/2025 |
BMO |
AUTL |
Autolus Therapeutics |
Q2 2025 |
REV |
12.91 M |
20.92 M |
62.13 |
|
0.00 |
|
| 05/08/2025 |
BMO |
AUTL |
Autolus Therapeutics |
Q1 2025 |
EPS |
-0.25 |
-0.26 |
-4.00 |
-0.24 |
-8.30 |
Healthcare / Biotechnology |
| 05/08/2025 |
BMO |
AUTL |
Autolus Therapeutics |
Q1 2025 |
REV |
2.07 M |
8.98 M |
334.96 |
10.09 M |
-10.99 |
Healthcare / Biotechnology |
Outlooks
* Growth at Outlook Mid-point against Estimate
Ratings
| 04/09/2026 |
AUTL |
Needham |
Buy |
Buy |
Maintain |
| 03/31/2026 |
AUTL |
Mizuho |
Outperform |
Outperform |
Maintain |
| 03/27/2026 |
AUTL |
Needham |
Buy |
Buy |
Maintain |
| 01/12/2026 |
AUTL |
Needham |
Buy |
Buy |
Maintain |
Dividends
Sign-Up to see the full list of CATALYSTS in the Calendars
<<Back to Stock Screener>>
